Founder & CIO at Northpoint Capital
Ultrahuman
Ultrahuman builds a metabolic health platform combining wearable smart rings, continuous glucose monitoring, and blood biomarker analysis to deliver real-time, personalized health insights. Its ecosystem tracks sleep, recovery, activity, and glucose response, with a clinically validated Metabolic Score and an AI-powered analytics layer. The platform serves both consumers and researchers, with developer APIs and enterprise solutions available.
- Artificial Intelligence
- Data & Analytics
- Consumer Electronics
- Digital Health
- Hardware
- Healthcare Technology
- Internet of Things
- Software Only
- Wellness & Fitness Technology
Updated 2 months ago
Funding
Raised to date
$117.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 3 rounds
+6$65M · Series C
Announced Sep 2026 · from article date
Disclosed cumulative: $117.5M
3/3
RoundDateAmountValuationInvestors
Founders
Product
Problem
Over a billion people worldwide suffer from metabolic health disorders, with many more exhibiting early precursors. Traditional health metrics like BMI, weight, and point-in-time blood tests fail to capture the full impact of lifestyle choices on metabolic health, leaving individuals without actionable, real-time feedback on how their bodies respond to food, exercise, and sleep.
Solution
Ultrahuman provides a comprehensive metabolic health platform that uses wearable sensors and biomarker tracking to deliver deeply personalized, real-time health insights. The ecosystem includes the Ultrahuman Ring for continuous sleep, recovery, and activity monitoring, the M2 Live continuous glucose monitor for tracking glucose responses to food and exercise, and Blood Vision for analyzing 100+ blood markers. The platform translates this data into actionable nudges and personalized recommendations, helping users optimize nutrition, exercise, and sleep based on their unique physiology. A clinically validated Metabolic Score, developed through peer-reviewed research, serves as a marker of insulin sensitivity and glucose metabolism, while the Pulsomics initiative leverages a foundational model of the human pulse to contribute to scientific research.
Target Audience
Primary customers are health-conscious consumers seeking to optimize metabolic health, manage weight, improve athletic performance, or manage conditions like prediabetes, PCOS, and hypertension, as well as researchers and enterprises requiring biomarker-driven health analytics.
Features
- Ultrahuman Ring PRO with up to 15-day battery life, fighter jet-grade titanium construction, and 250 days of on-ring data storage
- M2 Live continuous glucose monitoring using Abbott's Libre 3 Plus and Lingo sensors, with no prescription required in the US
- Blood Vision testing that decodes 100+ blood markers into personalized supplement plans and lifestyle recommendations
- PowerPlugs app store offering specialized features including AFib detection, migraine insights, and cycle tracking with ovulation prediction
- Clinically validated Metabolic Score published in Nature Scientific Reports as a marker of insulin sensitivity
- Pulsomics foundational model of the human pulse for scientific research contribution
- Ultrasignal developer API and UltraWork enterprise solutions for B2B applications